I hadn't heard the VRUS presentation till today but did read Adam's column after which I expected the stock would be down in the $5-$10 range today (currently down .20). I should have known better though as his bias towards VRTX has been quite evident.
They (VRUS) indicated that the kidney tox did not show up in the 28 day monkey studies and since they are not sacrificed during the study could not say when in the 13 weeks it starts to occur. They believe it is dose dependent (did not elaborate to a great deal on what specific doses). They also said 6 month tox studies (sorry I didn't catch what doses) are going well and currently at month 5 (these studies are not needed to proceed to Phase 2). My impression is that the 7128 is far from dead and Phase 2 trials should proceed shortly.
Market Data 
Markets 
AI
